SHH · 603538.SS
Ningbo Menovo Pharmaceutical Co., Ltd.
CN¥20.71+CN¥0.43 (+2.12%)
Ningbo Menovo Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 58.81% below the high.
Loading market information…
SHH · 688276.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:15 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Changchun BCHT Biotechnology Co.’s quoted price sits in the lower half of its reported 52-week range, 36.45% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Changchun BCHT Biotechnology Co.’s forward annual dividend is CN¥0.17 per share, paid annual. The forward yield is 1.09% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Changchun BCHT Biotechnology Co.’s next earnings report is currently expected on Oct 30, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Changchun BCHT Biotechnology Co.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Changchun BCHT Biotechnology Co. Ltd. is a biopharmaceutical enterprise primarily focused on the research, development, production, and global commercialization of vaccines designed for human use. Its extensive product portfolio features key immunizations such as attenuated (live) herpes zoster and varicella vaccines, alongside a live, nasal, and freeze-dried influenza vaccine, and a rabies vaccine utilizing vero cell technology. This company was established in 2004 and is headquartered in Changchun, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:30 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Oct 25, 2024 |
| CN¥0.26 |
| CN¥407.61M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥20.71+CN¥0.43 (+2.12%)
Ningbo Menovo Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 58.81% below the high.
CN¥11.07-CN¥0.08 (-0.72%)
Jiangsu Yahong Meditech Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 38.87% below the high.
CN¥4.77CN¥0.00 (0.0%)
Tianjin Tianyao Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.48% below the high.
CN¥8.52-CN¥0.04 (-0.47%)
HPGC Renmintongtai Pharmaceutical Corporation’s quoted price sits in the lower half of its reported 52-week range, 53.01% below the high.
CN¥8.15+CN¥0.16 (+2.0%)
Beijing Beilu Pharmaceutical Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 28.38% below the high.
CN¥8.74+CN¥0.19 (+2.22%)
Teyi Pharmaceutical Group Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.47% below the high.
CN¥10.04+CN¥0.27 (+2.76%)
Hunan Fangsheng Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.63% below the high.
CN¥3.58+CN¥0.03 (+0.85%)
Fuan Pharmaceutical (Group) Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 28.4% below the high.
